BIOMAT Database Logo BIOMAT Database Logo

[Effect of alpha-blocker and beta-blocker on in vitro pheochromocytoma tissue (author's transl)]. 1979

T Nakai, and R Yamada

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010643 Phenoxybenzamine An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator. Dibenylene,Dibenyline,Dibenziran,Dibenzylin,Dibenzyline,Dibenzyran,Phenoxybenzamine Hydrochloride,Hydrochloride, Phenoxybenzamine
D010646 Phentolamine A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease. Fentolamin,Phentolamine Mesilate,Phentolamine Mesylate,Phentolamine Methanesulfonate,Phentolamine Mono-hydrochloride,Regitine,Regityn,Rogitine,Z-Max,Mesilate, Phentolamine,Mesylate, Phentolamine,Methanesulfonate, Phentolamine,Mono-hydrochloride, Phentolamine,Phentolamine Mono hydrochloride
D010673 Pheochromocytoma A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298) Pheochromocytoma, Extra-Adrenal,Extra-Adrenal Pheochromocytoma,Extra-Adrenal Pheochromocytomas,Pheochromocytoma, Extra Adrenal,Pheochromocytomas,Pheochromocytomas, Extra-Adrenal
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Nakai, and R Yamada
[Beta-blocker (author's transl].
May 1979, Kokyu to junkan. Respiration & circulation,
T Nakai, and R Yamada
[Effect of the beta-receptor-blocker prindolol on renal hypertension (author's transl)].
November 1976, Klinische Wochenschrift,
T Nakai, and R Yamada
[Withdrawal syndrome following beta blocker therapy (author's transl)].
October 1981, MMW, Munchener medizinische Wochenschrift,
T Nakai, and R Yamada
[On the pharmacology of the beta-receptor blocker penbutolol (author's transl)].
January 1980, Arzneimittel-Forschung,
T Nakai, and R Yamada
[Plasma dopamine-beta-hydroxylase activity in pheochromocytoma (author's transl)].
January 1980, Annales d'endocrinologie,
T Nakai, and R Yamada
[Effect of alpha and beta-adrenergic blockades on plasma renin activity (author's transl)].
May 1977, Nihon Jinzo Gakkai shi,
T Nakai, and R Yamada
[Treatment of hypertension: diuretic or beta-blocker? (author's transl)].
November 1979, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
T Nakai, and R Yamada
[Pheochromocytoma (author's transl)].
January 1977, Revista medica de Chile,
T Nakai, and R Yamada
Effect of an alpha-blocker (Nicergoline) and of a beta-blocker (Acebutolol) on the in vitro biosynthesis of vascular extracellular matrix.
May 2001, Pathologie-biologie,
T Nakai, and R Yamada
[Amebicidal and trichomonacidal activity in vitro of beta-nitrosyrenes, alpha-nitrostilbenes and alpha or beta substituted analogs (author's transl)].
January 1978, Annales pharmaceutiques francaises,
Copied contents to your clipboard!